Waiting Period Between Knee Injection and Surgery
For corticosteroid injections, wait at least 3 months before proceeding to knee replacement surgery; for hyaluronic acid injections, the same 3-month waiting period is recommended to minimize infection risk.
Corticosteroid Injections
The evidence consistently supports a 3-month waiting period for corticosteroid injections prior to knee arthroplasty:
The 2020 VA/DoD Clinical Practice Guideline explicitly states that corticosteroid injection should be avoided for 3 months preceding joint replacement surgery 1.
The 2021 EULAR recommendations indicate that intra-articular therapy may be performed at least 3 months prior to joint replacement surgery, noting that the rate of prosthetic infections was significantly higher in groups receiving injections 0-3 months before surgery (increasing from 0.5% to 1.0%), but not when injections were separated from surgery by longer than 3 months 2.
Recent meta-analysis data confirms that corticosteroid injections within 3 months before arthroplasty were associated with increased risk of periprosthetic joint infection (OR 1.39, p=0.03), while injections given 3-6 months or 6-12 months before surgery showed no increased infection risk 3.
More granular analysis suggests the highest risk occurs within 2-4 weeks of surgery, with one study identifying injections within 2 weeks as an independent risk factor (OR 2.89, p=0.04) 4. However, the conservative 3-month recommendation remains the guideline standard 1, 2.
Hyaluronic Acid Injections
The evidence for hyaluronic acid follows a similar pattern to corticosteroids:
Hyaluronic acid injections given ≤3 months before total knee arthroplasty increase the risk of periprosthetic joint infection (OR 1.55, p=0.029), with no increased risk when given >3 months prior to surgery 5.
Direct comparison shows no significant difference in infection risk between corticosteroid and hyaluronic acid injections when given in the same timeframe 5.
The 2023 ACR/AAHKS guideline conditionally recommends proceeding to total joint arthroplasty without delay over delaying for a trial of viscosupplementation injections in patients with moderate-to-severe osteoarthritis who have already failed nonoperative therapy 6, 7. However, this recommendation applies to the defined population who are already surgical candidates, not to the timing after an injection has already been given.
Important Caveats and Clinical Context
The 2023 ACR/AAHKS guideline represents a paradigm shift by conditionally recommending against mandatory 3-month waiting periods for patients who are already appropriate surgical candidates with failed conservative management 6, 7. This guideline emphasizes that patients in their defined population have already attempted nonoperative treatment for extended periods, and further arbitrary delays may worsen quality of life 6.
However, this recommendation addresses whether to delay surgery for a trial of injections, not the safety window after an injection has already been administered. The infection risk data remains clear that if an injection has been given, waiting 3 months reduces infection risk 1, 2, 3, 5.
Risk Stratification
Tobacco use is an additional risk factor that further increases the likelihood of periprosthetic joint infection in patients who receive preoperative injections 8.
Patients with diabetes, especially those with suboptimal control, should be informed about transient hyperglycemia risk following corticosteroid injection (typically days 1-3 post-injection) 2.
The absolute increase in infection risk is modest but clinically significant: background infection rates of 1.04-2.5% increase to approximately 1.0% with injections within 3 months 2.
Practical Algorithm
If a patient has received a corticosteroid or hyaluronic acid injection: Wait 3 months before scheduling knee arthroplasty 1, 2, 3, 5.
If a patient is already an appropriate surgical candidate with failed conservative management: Consider proceeding directly to surgery rather than attempting injections as a delaying tactic 6, 7.
If surgery must be performed urgently within 3 months of injection (e.g., severe osteonecrosis with intractable pain): Proceed with shared decision-making, acknowledging the modestly increased infection risk 2.
For patients with additional risk factors (tobacco use, poorly controlled diabetes): Strongly adhere to the 3-month waiting period and optimize modifiable risk factors 8.